Studies comparing the effectiveness of medical treatments have the potential to reduce health care costs by helping purchasers, such as Medicare, eliminate low-value services. Health care analysts generally agree that current institutions underproduce comparative-effectiveness research, and economists agree that private sector tends to underproduce such public goods. Many, therefore, want Congress to fund such research. But is market failure really the culprit? And would taxpayer-funded research solve the problem, or would it lead to government rationing? Or would it have no effect on health care costs?
Featuring the author Angus Deaton, Dwight D. Eisenhower Professor of Economic and International Affairs, Woodrow Wilson School of Public and International Affairs & Economics Department, Princeton University; with comments by Charles Kenny, Senior Fellow, Center for Global Development; moderated by Ian Vasquez, Director, Center for Global Liberty and Prosperity, Cato Institute.
- Legal Briefs
- Cato Handbook for Policymakers
- Cato Journal
- Cato's Letter
- Cato's Letters
- Cato Papers on Public Policy
- Cato Policy Report
- Cato State Legislative Guide
- Cracking the Books
- Economic Freedom of the States of India
- Economic Freedom of the World
- Public Comments
- Supreme Court Review
December 6, 2013
Tim Lynch discusses the rising number of arrested D.C. police department officers on WUSA’s 9 News at 6pm
December 5, 2013
Interest rates should be determined by the interaction of savers and investors, not driven by the arbitrary whims of government officials in Washington.
The 2008-2009 financial crisis and Great Recession have vastly increased the power and scope of the Federal Reserve, and radically changed the financial landscape. This new ebook examines those changes and considers how the links between money, markets, and government may evolve in the future.